Bridget E. Bunner

Array ( [id] => 1413980 [patent_doc_number] => 06518011 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Method for screening compounds to identify beta-amyloid production modulators' [patent_app_type] => B1 [patent_app_number] => 09/481980 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 8936 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518011.pdf [firstpage_image] =>[orig_patent_app_number] => 09481980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553269 [patent_doc_number] => 06348330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Method for measuring human neurokinin-3 receptor ligand binding' [patent_app_type] => B1 [patent_app_number] => 09/482971 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5903 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348330.pdf [firstpage_image] =>[orig_patent_app_number] => 09482971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1496072 [patent_doc_number] => 06403764 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Insulin-like growth factor-1 protein variants' [patent_app_type] => B1 [patent_app_number] => 09/477924 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 23613 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403764.pdf [firstpage_image] =>[orig_patent_app_number] => 09477924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286872 [patent_doc_number] => 06635445 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Nucleic acid molecules encoding human luteinizing hormone-human chorionic gonadotropin receptor protein and transformants thereof' [patent_app_type] => B1 [patent_app_number] => 09/461657 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 17903 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635445.pdf [firstpage_image] =>[orig_patent_app_number] => 09461657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558444 [patent_doc_number] => 06436389 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Stimulation of cell proliferation by glycosylated cystatin C' [patent_app_type] => B1 [patent_app_number] => 09/459958 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 16932 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436389.pdf [firstpage_image] =>[orig_patent_app_number] => 09459958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1354457 [patent_doc_number] => 06572851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-03 [patent_title] => 'Method for suppressing or treating drug-induced nephropathy' [patent_app_type] => B2 [patent_app_number] => 09/380882 [patent_app_country] => US [patent_app_date] => 1999-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 4999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/572/06572851.pdf [firstpage_image] =>[orig_patent_app_number] => 09380882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095757 [patent_doc_number] => 20020052020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Novel orphan receptors' [patent_app_type] => new [patent_app_number] => 09/442356 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6981 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052020.pdf [firstpage_image] =>[orig_patent_app_number] => 09442356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416889 [patent_doc_number] => 06514728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Process for preparation of cytokines using Sendai virus expression system' [patent_app_type] => B1 [patent_app_number] => 09/436504 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514728.pdf [firstpage_image] =>[orig_patent_app_number] => 09436504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311908 [patent_doc_number] => 06610540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Low oxygen culturing of central nervous system progenitor cells' [patent_app_type] => B1 [patent_app_number] => 09/425462 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 19094 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610540.pdf [firstpage_image] =>[orig_patent_app_number] => 09425462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602465 [patent_doc_number] => 06432643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method of determining Alzheimer\'s disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels' [patent_app_type] => B1 [patent_app_number] => 09/425650 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3446 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432643.pdf [firstpage_image] =>[orig_patent_app_number] => 09425650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476676 [patent_doc_number] => 06451303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Method of treating coronary artery disease by administering a recombinant FGF' [patent_app_type] => B1 [patent_app_number] => 09/417721 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 18890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451303.pdf [firstpage_image] =>[orig_patent_app_number] => 09417721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269639 [patent_doc_number] => 06653088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the -amyloid peptide' [patent_app_type] => B1 [patent_app_number] => 09/415099 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 18151 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653088.pdf [firstpage_image] =>[orig_patent_app_number] => 09415099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264018 [patent_doc_number] => 06660467 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Variant of ciliary neurotrophic factor and DNA encoding the variant' [patent_app_type] => B1 [patent_app_number] => 09/381393 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4369 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660467.pdf [firstpage_image] =>[orig_patent_app_number] => 09381393 [rel_patent_id] =>[rel_patent_doc_number] =>)